Once-monthly paliperidone palmitate in recently diagnosed and chronic non-acute patients with schizophrenia.

Reductions in the IEQ total score were also observed in recently diagnosed and chronic patients but these changes did not reach statistical significance; this may be partly due to lack of statistical power because of the small number of carers assessed. 3.4 Functioning outcomes From baseline to endpoint, the mean PSP total score increased from 59.2 to 67.7 in recently diagnosed patients and from 57.4 to 65.0 in chronic patients ( p < 0.0001 for both groups, Wilcoxon signed-rank test).

also in 111,027 other papers